Espinosa Karina, Bossé Ynuk, Stankova Jana, Rola-Pleszczynski Marek
Immunology Division, Department of Pediatrics, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
J Allergy Clin Immunol. 2003 May;111(5):1032-40. doi: 10.1067/mai.2003.1451.
Airway remodeling is a feature of chronic asthma. It involves a number of structural changes, including bronchial smooth muscle cell (BSMC) hyperplasia and hypertrophy. Cysteinyl leukotrienes (cysLTs) have been suggested to play a role in airway remodeling in addition to their numerous other physiopathologic effects.
This work was aimed at characterizing the potential modulation of CysLT1 receptor expression by cytokines and the eventual functional relevance of this modulation.
Expression of CysLT1 receptor was measured by flow cytometry and immunofluorescence microscopy. Transcripts were measured by RT-PCR and BSMC proliferation by crystal violet staining.
When human BSMC were exposed to transforming growth factor (TGF)-beta, IL-13, or IFN-gamma, their expression of CysLT1 receptor was significantly augmented in a time- and concentration-dependent manner. Interestingly, IL-4 had no significant effect on CysLT1 receptor expression in BSMC. Moreover, IL-13 and IFN-gamma but not TGF-beta were able to increase CysLT1 mRNA levels. Finally, when BSMC were pretreated with TGF-beta or IL-13 but not IFN-gamma, their responsiveness to LTD(4) was markedly enhanced in terms of BSMC proliferation. Whereas TGF-beta, IL-13, or LTD(4) alone had little effect on BSMC proliferation, preexposure of the cells to TGF-beta or IL-13 for 24 hours resulted in a significant increase in proliferation in response to LTD(4). The enhanced proliferation was totally prevented by pretreating the cytokine-primed BSMC with the selective CysLT1 receptor antagonist Montelukast.
Taken together, our findings indicate a synergy between certain cytokines and cysLTs, mediated by the augmented expression of the CysLT1 receptor and subsequent LTD(4)-triggered BSMC proliferation. These findings support a role for cysLTs in the airway remodeling observed in asthmatic patients and may provide a rationale for preventive and therapeutic intervention.
气道重塑是慢性哮喘的一个特征。它涉及多种结构变化,包括支气管平滑肌细胞(BSMC)的增生和肥大。除了其众多其他生理病理作用外,半胱氨酰白三烯(cysLTs)已被认为在气道重塑中起作用。
这项工作旨在表征细胞因子对CysLT1受体表达的潜在调节作用以及这种调节的最终功能相关性。
通过流式细胞术和免疫荧光显微镜测量CysLT1受体的表达。通过RT-PCR测量转录本,并通过结晶紫染色测量BSMC增殖。
当人BSMC暴露于转化生长因子(TGF)-β、IL-13或IFN-γ时,它们的CysLT1受体表达以时间和浓度依赖性方式显著增加。有趣的是,IL-4对BSMC中CysLT1受体的表达没有显著影响。此外,IL-13和IFN-γ而非TGF-β能够增加CysLT1 mRNA水平。最后,当BSMC用TGF-β或IL-13而非IFN-γ预处理时,就BSMC增殖而言,它们对LTD4的反应性显著增强。虽然单独的TGF-β、IL-13或LTD4对BSMC增殖几乎没有影响,但将细胞预先暴露于TGF-β或IL-13 24小时会导致对LTD4的增殖反应显著增加。用选择性CysLT1受体拮抗剂孟鲁司特预处理细胞因子引发的BSMC可完全阻止增殖增强。
综上所述,我们的研究结果表明某些细胞因子和cysLTs之间存在协同作用,这是由CysLT1受体表达增加以及随后LTD4触发的BSMC增殖介导的。这些发现支持cysLTs在哮喘患者气道重塑中的作用,并可能为预防和治疗干预提供理论依据。